Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...
Hosted on MSN
Rutgers licenses new non-opioid chronic pain treatment compound to Tonix Pharmaceuticals
NEW BRUNSWICK, NJ — Rutgers University just granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize PW507, a new type of compound medicine invented by researchers at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results